ITM 14D
Alternative Names: Gallium-168 drug conjugate; ITM-14DLatest Information Update: 08 Oct 2024
At a glance
- Originator ITM Solucin
- Class Diagnostic agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neuroendocrine tumours
Most Recent Events
- 11 Sep 2024 Launched for Neuroendocrine tumours (Diagnosis) in Austria, France, Germany (unspecified route) (ITM Solucin pipelines; September 2024)
- 11 Sep 2024 Registered for Neuroendocrine tumours (Diagnosis) in Germany, France, Austria (unspecified route) before September 2024 (ITM Solucin pipelines; September 2024)